Your Article Summary
See Latest ArticlesViro-Immunologic Response to Ritonavir-Boosted or Unboosted Atazanavir in a Large Cohort of Multiply Treated Patients
AIDS Patient Care and STDs, 01/22/08
Santoro MM et al. - Currently, comparative data able to define the potency of boosted versus unboosted atazanavir in highly pretreated HIV-infected patients are limited. Specifically, in clinical practice it is very important to establish whether atazanavir-boosting with ritonavir warrants potency and efficacy that overcome the profile of unboosted drug
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhibition of Herpes Simplex Virus Type 1 By the Experimental Immunosuppressive Agent Leflunomide
Transplantation, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
The efficacy and safety of telaprevir ? a new protease inhibitor against hepatitis C virus
Expert Opinion on Investigational Drugs, 12/16/09